Kyowa Kirin

Kyowa Kirin Co., Ltd.
FormerlyKyowa Hakko Kogyo Co., Ltd. (1949–2008)
Kyowa Hakko Kirin Co., Ltd. (2008-2019)
TypePublic
TYO: 4151
Nikkei 225 Component
Industry
PredecessorKirin Pharma
FoundedJuly 1, 1949 (1949-07-01)
HeadquartersOhtemachi Building, 1-6-1, Ōtemachi, ,
Japan
Key peopleNobuo Hanai, (CEO and president)
Products
Revenue$ 2.99 billion USD (FY 2022) Increase (¥ 398.4 billion JPY) (FY 2022)
$ 375 million USD (FY 2022) Increase (¥ 53.6 billion JPY) (FY 2022)
Number of employees
7,532 (consolidated) (as of December 31, 2017)
ParentKirin Holdings Company, Limited
Subsidiaries47 (33 in Japan and 14 overseas countries)
WebsiteOfficial website
Footnotes

Kyowa Kirin Co., Ltd. (協和キリン株式会社, Kyōwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and was among the 40 largest in the world by revenue in 2012. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.